netFormulary Joint Medicines Formulary NHS
Airedale NHS Foundation Trust
Airedale, Wharfedale and Craven CCG
 
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:

Within Airedale NHS Foundation Trust It is important to use antimicrobials in line with the antimicrobial use policy to

  • prevent unnecessary secondary infections, such as Clostridium difficile
  • Reduce the risk of resistance developing, so that future patients can receive the benefits of antimicrobials
  • Ensure the best outcomes for the patient
  • Not waste time and money on inappropriate therapy

Local guidance on the treatment of common infections is available and advice on antimicrobial therapy can be obtained from the Consultant Microbiologist, bleep via switchboard, or the Antimicrobial Lead Pharmacist, Kevin Frost via bleep 3091.

Within Airedale Wharfedale Craven CCG antimicrobial guidance can be found at this link - Summary of antimicrobial prescribing guidance - managing common infections

Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand.

Otitis media (acute): antimicrobial prescribing

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (3,0)
05.01.01.02 Penicillinase-resistant penicillins (1,0)
05.01.01.03 Broad-spectrum penicillins (2,0)
05.01.01.04 Antipseudomonal penicillins (1,0)
05.01.01.05 Mecillinams (1,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactams (0,0)
Cephalosporins (7,0)
Other beta-lactam antibiotics (0,0)
05.01.02.01 Cephalosporins (0,0)
05.01.02.02 Carbapenems (1,0)
05.01.02.03 Other beta-lactams antibiotics (1,0)
05.01.03 Tetracyclines (4,0)
Tigecycline (1,0)
05.01.04 Aminoglycosides (3,0)
05.01.05 Macrolides (3,0)
05.01.06 Clindamycin (1,0)
05.01.07 Some other antibacterials (3,0)
Chloramphenicol (1,0)
Fusidic acid (1,0)
Vancomycin and teicoplanin (4,0)
Daptomycin (1,0)
Linezolid (1,0)
Quinupristin and dalfopristin (0,0)
Polymyxins (0,0)
05.01.08 Sulphonamides and trimethoprim (2,0)
05.01.09 Antituberculosis drugs (5,0)
05.01.10 Antileprotic drugs (1,0)
05.01.11 Metronidazole and tinidazole (1,0)
05.01.12 Quinolones (3,0)
05.01.13 Urinary-tract infections (1,0)
05.02 Antifungal drugs (7,0)
05.03 Antiviral drugs (0,0)
05.03.01 HIV infection (1,1)
Nucleoside reverse transcriptase inhibitors (2,0)
Other antiretrovirals (0,0)
05.03.02 Herpesvirus infections (0,0)
05.03.02.01 Herpes simplex and varicella-zoster infection (1,0)
05.03.02.02 Cytomegalovirus infrection (1,0)
05.03.03 Viral hepatitis (0,0)
05.03.03.01 Chronic hepatitis B (2,0)
05.03.03.02 Chronic hepatitis C (13,0)
05.03.04 Influenza (2,0)
05.03.05 Respiratory syncytial virus (2,0)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Treatment of malaria (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Prophylaxis against malaria (0,0)
Specific recommendations (0,0)
Artemether with lumefabtrine (0,0)
Chloroquine (1,0)
Mefloquine (0,0)
Primaquine (0,0)
Proguanil (1,0)
Pyrimethamine (0,0)
Quinine (1,0)
Tetracyclines (0,0)
05.04.02 Amoebicides (0,0)
05.04.03 Trichomonacides (0,0)
05.04.04 Antigiardial drugs (0,0)
05.04.05 Leishmaniacides (0,0)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (0,0)
05.04.08 Drugs for pneumocystis pneumonia (0,0)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (1,0)
05.05.02 Ascaricides (0,0)
05.05.03 Drugs for tapeworm infections (0,0)
Taenicides (0,0)
Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (0,0)
05.05.06 Filaricides (0,0)
05.05.07 Drugs for cutaneous larva migrans (0,0)
05.05.08 Drugs for strongyloidiasis (0,0)
netFormulary